A critical advance in cancer study is arising with the use of mini-antibodies to restore mutated p53. This crucial malignant inhibitor protein is frequently disabled in many types of cancer, leading uncontrolled tissue https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research